CARDIOLITE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Cardiolite, and what generic alternatives are available?

Cardiolite is a drug marketed by Lantheus Medcl and is included in one NDA.

The generic ingredient in CARDIOLITE is technetium tc-99m sestamibi kit. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the technetium tc-99m sestamibi kit profile page.

Summary for CARDIOLITE

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Clinical Trials:	10
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CARDIOLITE
What excipients (inactive ingredients) are in CARDIOLITE?	CARDIOLITE excipients list
DailyMed Link:	CARDIOLITE at DailyMed

Drug patent expirations by year for CARDIOLITE

Recent Clinical Trials for CARDIOLITE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GE Healthcare	Early Phase 1
M.D. Anderson Cancer Center	Early Phase 1
National Cancer Institute (NCI)	Early Phase 1

See all CARDIOLITE clinical trials

US Patents and Regulatory Information for CARDIOLITE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lantheus Medcl	CARDIOLITE	technetium tc-99m sestamibi kit	INJECTABLE;INJECTION	019785-001	Dec 21, 1990	AP	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CARDIOLITE

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lantheus Medcl	CARDIOLITE	technetium tc-99m sestamibi kit	INJECTABLE;INJECTION	019785-001	Dec 21, 1990	⤷ Try a Trial	⤷ Try a Trial
Lantheus Medcl	CARDIOLITE	technetium tc-99m sestamibi kit	INJECTABLE;INJECTION	019785-001	Dec 21, 1990	⤷ Try a Trial	⤷ Try a Trial
Lantheus Medcl	CARDIOLITE	technetium tc-99m sestamibi kit	INJECTABLE;INJECTION	019785-001	Dec 21, 1990	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CARDIOLITE

See the table below for patents covering CARDIOLITE around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Denmark	174300		⤷ Try a Trial
Japan	H0339515		⤷ Try a Trial
Spain	2001867	METODO Y EQUIPO DE PREPARACION DE UN COMPLEJO DE COORDINACION DE UN LIGANDO ISONITRILO Y UN METAL RADIACTIVO (Metal-Isonitrile adducts for preparing radionuclide complexes.)	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for CARDIOLITE

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0107734	SPC/GB93/166	United Kingdom	⤷ Try a Trial	SPC/GB93/166, EXPIRES: 20050816
1178838	300736	Netherlands	⤷ Try a Trial	PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
0107734	93C0042	Belgium	⤷ Try a Trial	PROD. NAME TETRAKIS (2-METHOXY-ISOBUTYL-ISONITRILE). CUIVRE (I) TETRAFLUOROBORATE, DIHYDRATE DE CHLORURE STANNEUX, CHLORHYDRATE DE L-CYSTEINE (MONOHYDRATE); REG NO/DATE 923 IS 3 F 12/ 19900924 ; FIRST REG CC NO DATE IE PA 200/9/1 19900817
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Summary for CARDIOLITE

Recent Clinical Trials for CARDIOLITE

Make Better Decisions: Try a trial or see plans & pricing